GENMAB A/S

10% Owner · Merus N.V.

Every open-market stock purchase GENMAB A/S has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.

Total bought
$7.6B
Open-market buys
11
Companies
1
Last buy
Dec 29, 2025

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
Dec 29, 20251,052,806$97.00$102.1MSEC ↗
Dec 29, 202575,867,199$97.00$7.4BSEC ↗
Dec 26, 20252,978$97.00$288.9KSEC ↗
Dec 26, 2025142,610$97.00$13.8MSEC ↗
Dec 24, 202596,082$97.00$9.3MSEC ↗
Dec 23, 2025561,042$97.00$54.4MSEC ↗
Dec 22, 202515,710$97.00$1.5MSEC ↗
Dec 19, 202566,264$97.00$6.4MSEC ↗
Dec 18, 2025212,177$97.00$20.6MSEC ↗
Dec 17, 2025150,795$97.00$14.6MSEC ↗
Dec 16, 2025120,752$97.00$11.7MSEC ↗

Get alerted the next time GENMAB A/S — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from GENMAB A/S's Form 4 filings on SEC EDGAR (CIK 1434265) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.